Skip to content

Lantheus Holdings, Inc. (LNTH) stock: revenue, earnings & dividend

Lantheus Holdings, Inc. (LNTH, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener LNTH · Nasdaq Pharma & Biotech US-MA

Key figures

Fiscal year
2025
Revenue
1.54 bn $
Revenue growth
0.5 %
Revenue growth 5y (p.a.)
35.4 %
Net income
234 m $
Net margin
15.2 %
Operating margin
20.2 %
Earnings per share (diluted)
3.41 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
2.23 bn $
Equity
1.09 bn $
Equity ratio
48.9 %
Return on equity
21.4 %
Cash
359 m $
Operating cash flow
390 m $
Free cash flow
–
Shares outstanding
65,401,413

History

Revenue by fiscal year

2016 302 m $
2017 331 m $
2018 343 m $
2019 347 m $
2020 339 m $
2021 425 m $
2022 935 m $
2023 1.3 bn $
2024 1.53 bn $
2025 1.54 bn $

Net income by fiscal year

2017 123 m $
2018 40.5 m $
2019 31.7 m $
2020 -13.47 m $
2021 -71.28 m $
2022 28.1 m $
2023 327 m $
2024 312 m $
2025 234 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.54 bn $234 m $3.41 $–390 m $
20241.53 bn $312 m $4.36 $–545 m $
20231.3 bn $327 m $4.65 $–305 m $
2022935 m $28.1 m $0.40 $–282 m $
2021425 m $-71.28 m $-1.06 $–53.9 m $
2020339 m $-13.47 m $-0.25 $–16.4 m $
2019347 m $31.7 m $0.79 $–80.4 m $
2018343 m $40.5 m $1.03 $–61.2 m $
2017331 m $123 m $3.17 $–54.8 m $
2016302 m $–0.82 $–49.6 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)